| Report ID | Date of report | Patient age | Patient gender |
| 117045 | May, 16, 2006 | 57 | Female |
List of drugs the patient takes:
| Drug | Ingredient(s) |
Vioxx | rofecoxib |
Norvasc | amlodipine besylate |
Dyazide | hydrochlorothiazide; triamterene |
Aldomet | methyldopa |
Lasix | furosemide |
Celexa | citalopram hydrobromide |
Lortab | acetaminophen; hydrocodone bitartrate |
| Name |
Abdominal Discomfort |
Anaemia |
Angina Unstable |
Anxiety |
Blood Cholesterol Increased |
Bradycardia |
Cardiac Failure Congestive |
Coronary Artery Disease |
Deep Vein Thrombosis |
Dilatation Atrial |
Drug Intolerance |
Fear |
Herpes Zoster |
Hyperlipidaemia |
Hypokalaemia |
Low Density Lipoprotein Increased |
Myocardial Infarction |
Pain |
Phlebitis Superficial |
Pulmonary Embolism |
Pulmonary Valve Incompetence |
Systolic Hypertension |
Ventricular Fibrillation |
Ventricular Hypertrophy |
Results from eHealthMe : 5 report(s)
Comparison with the patient:
| Name | Count (% of total reports) |
Abdominal Discomfort | 4 (80.00%) |
Anaemia | 1 (20.00%) |
Angina Unstable | 2 (40.00%) |
Anxiety | 5 (100.00%) |
Blood Cholesterol Increased | 5 (100.00%) |
Bradycardia | 5 (100.00%) |
Cardiac Failure Congestive | 1 (20.00%) |
Coronary Artery Disease | 5 (100.00%) |
Deep Vein Thrombosis | 1 (20.00%) |
Dilatation Atrial | 5 (100.00%) |
Drug Intolerance | 3 (60.00%) |
Fear | 2 (40.00%) |
Herpes Zoster | 3 (60.00%) |
Hyperlipidaemia | 4 (80.00%) |
Hypokalaemia | 4 (80.00%) |
Low Density Lipoprotein Increased | 1 (20.00%) |
Myocardial Infarction | 5 (100.00%) |
Pain | 2 (40.00%) |
Phlebitis Superficial | 5 (100.00%) |
Pulmonary Embolism | 1 (20.00%) |
Pulmonary Valve Incompetence | 5 (100.00%) |
Systolic Hypertension | 5 (100.00%) |
Ventricular Fibrillation | 4 (80.00%) |
Ventricular Hypertrophy | 5 (100.00%) |
Top 3 (total: 0. Click here to see more) co-used drugs - potential interacting drugs:
Death reported: 0
| Name | Count (% of total reports) |
Phlebitis Superficial | 5 (100.00%) |
Pulmonary Valve Incompetence | 5 (100.00%) |
Systolic Hypertension | 5 (100.00%) |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Recent drug risk analysis reports:
